After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Immunovant Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Immunovant Inc is $2.59B. A total of 1.21 million shares were traded on the day, compared to an average of 1.81M shares.
In the most recent transaction, Stout Jay S sold 1,925 shares of IMVT for 14.79 per share on Apr 23 ’25. After the transaction, the Chief Technology Officer now owns 209,243 company shares. In a previous transaction on Apr 23 ’25, Geffner Michael sold 2,349 shares at 14.79 per share. IMVT shares that Chief Medical Officer owns now total 225,370.
Among the insiders who sold shares, Barnett Eva Renee disposed of 2,993 shares on Apr 16 ’25 at a per-share price of $14.89. This resulted in the Chief Financial Officer holding 396,774 shares of IMVT after the transaction. In another insider transaction, Salzmann Peter sold 8,321 shares at $14.89 per share on Apr 16 ’25. Company shares held by the Chief Executive Officer now total 1,178,191.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, IMVT has a high of $34.47 and a low of $12.72.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IMVT’s latest balance sheet shows that the firm has $493.82M in Cash & Short Term Investments as of fiscal 2022. There were $2.36M in debt and $44.52M in liabilities at the time. Its Book Value Per Share was $2.40, while its Total Shareholder’s Equity was $469.82M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMVT is Buy with a score of 4.60.
